ORCID "Doğan, İzzet/0000-0003-1018-1119" WoS İndeksli Yayınlar Koleksiyonu için listeleme
-
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Özdemir, Özlem; Zengel, Baha; Yıldız, Yaşar; Uluç, Başak Oyan; Çabuk, Devrim; Ozden, Ercan; Alacacıoğlu, Ahmet; Avcı, Okan (Lippincott Williams & Wilkins, 2022)In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...